Ambulatory blood pressure monitoring and "white coat" hypertension: saving costs

Barry P McGrath
Med J Aust 2002; 176 (12): . || doi: 10.5694/j.1326-5377.2002.tb04585.x
Published online: 17 June 2002

Appropriate use of ambulatory blood pressure monitoring can be cost effective

The rationale for the use of ambulatory blood pressure monitoring (ABPM) has been the subject of critical reviews and published guidelines.1-6 Perhaps the most important and challenging finding to emerge from ambulatory blood pressure research has been the detection of "white coat" hypertension (also known as isolated clinic hypertension) in about 20% of subjects with repeatedly elevated casual blood pressure readings taken in the doctor's clinic.7,8 The condition can only be detected by ABPM or self-monitoring, and there are no specific predisposing factors. For people with white coat hypertension and no evidence of cardiovascular disease or comorbidities such as diabetes or renal disease, most experts agree that the best policy is to monitor their clinic blood pressure regularly, with self-monitoring at home, and repeat ABPM at one- to two-yearly intervals.

  • Department of Vascular Sciences, Dandenong Hospital, Dandenong, VIC.


  • 1. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure recording. American Society of Hypertension Ad Hoc Panel. Am J Hypertens 1996; 9: 1-11.
  • 2. Myers MG, Haynes RB, Rabkin SW. Canadian Hypertension Society guidelines for ambulatory blood pressure monitoring. Am J Hypertens 1999; 12: 1149-1157.
  • 3. O'Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000; 320: 1128-1134.
  • 4. Pickering T, James G, Boddie C, et al. How common is white coat hypertension? JAMA 1988; 259: 225-228.
  • 5. McGrath BP. Is white coat hypertension innocent? Lancet 1997; 348: 630.
  • 6. Palitini P, Mormino P, Santonastaso M, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31: 57-63.
  • 7. Yarrows SA, Khoury S, Sowers JR. Cost effectiveness of 24-hour ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens 1994; 7: 464-468.
  • 8. Pierdomenico SD, Mezzetti A, Lapenna D, et al. 'White-coat'' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 1995; 16: 692-697.
  • 9. Bidlingmeyer I, Burnier M, Bidlingmeyer M, et al. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14: 327-332.
  • 10. Ewald B, Pekarsky B. Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practice. Med J Aust 2002; 12: 580-583 <eMJA full text>
  • 11. Gourlay SG, McNeil JJ, Marriner T, et al. Discordance of mercury sphygmomanometer and ambulatory blood pressure measurements for the detection of untreated hypertension in a population study. J Hum Hypertens 1993; 7: 467-472.
  • 12. Staessen J, Byttebier G, Buntinx F, et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement: a randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997; 278: 1065-1072.
  • 13. Staessen J, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539-546.
  • 14. Silagy C, McNeil J, Farish S, McGrath B. Comparison of repeated measures of ambulatory and clinic blood pressure readings in isolated systolic hypertension. Clin Exp Hypertens 1993; 15: 895-909.
  • 15. Bellomo G, Narducci PL, Rondoni F, et al. Prognostic value of 24-hour blood pressure in pregnancy. JAMA 1999; 282: 1447-1452.
  • 16. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001; 322: 531-536.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.